Acute myeloid leukemic cell lines loaded with synthetic dsRNA trigger IFN-γ secretion by human NK cells

Leukemia Research

Volumn 33, Issue 4, 2009, Pages 539-546

  Lion, Eva ^a   Smits, Evelien L J M ^a   Berneman, Zwi N ^a,b   Van Tendeloo, Viggo F I ^a,b  

^a Faculty of Medicine   (Belgium)

^b ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Acute myeloid leukemia; dsRNA; Electroporation; Human NK cells; IFN ; Poly(I:C)

Indexed keywords

ALPHA INTERFERON; DOUBLE STRANDED RNA; GAMMA INTERFERON;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; ELECTROPORATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; NATURAL KILLER CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN SECRETION; REMISSION;

CELL COMMUNICATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; ELECTROPORATION; FLOW CYTOMETRY; HUMANS; INTERFERON INDUCERS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID, ACUTE; POLY I-C; RNA, DOUBLE-STRANDED;

EID: 60249095792     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.08.020     Document Type: Article

References (60)

1. Richards J.O., Chang X., Blaser B.W., Caligiuri M.A., Zheng P., and Liu Y. Tumor growth impedes natural-killer-cell maturation in the bone marrow. Blood 108 (2006) 246-252
2. Colucci F., Caligiuri M.A., and Di Santo J.P. What does it take to make a natural killer?. Nat Rev Immunol 3 (2003) 413-425
3. Wallace M.E., and Smyth M.J. The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity. Springer Semin Immunopathol 27 (2005) 49-64
4. Fauriat C., Just-Landi S., Mallet F., Arnoulet C., Sainty D., Olive D., et al. Deficient expression of NCR in NK cells from acute myeloid leukemia: evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction. Blood 109 (2007) 323-330
5. Tajima F., Kawatani T., Endo A., and Kawasaki H. Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia. Leukemia 10 (1996) 478-482
6. Costello R.T., Sivori S., Marcenaro E., Lafage-Pochitaloff M., Mozziconacci M.J., Reviron D., et al. Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 99 (2002) 3661-3667
7. Fauriat C., Moretta A., Olive D., and Costello R.T. Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients. Blood 106 (2005) 2186-2188
8. Deschler B., and Lubbert M. Acute myeloid leukemia: epidemiology and etiology. Cancer 107 (2006) 2099-2107
9. Galea-Lauri J. Immunological weapons against acute myeloid leukaemia. Immunology 107 (2002) 20-27
10. Cheuk A.T., Chan L., Czepulkowski B., Berger S.A., Yagita H., Okumura K., et al. Development of a whole cell vaccine for acute myeloid leukaemia. Cancer Immunol Immunother 55 (2006) 68-75
11. Terme M., Ullrich E., Delahaye N.F., Chaput N., and Zitvogel L. Natural killer cell-directed therapies: moving from unexpected results to successful strategies. Nat Immunol 9 (2008) 486-494
12. Velardi A., Ruggeri L., Alessandro, Moretta, and Moretta L. NK cells: a lesson from mismatched hematopoietic transplantation. Trends Immunol 23 (2002) 438-444
13. Costello R.T., Fauriat C., Rey J., Gastaut J.A., and Olive D. Immunobiology of haematological malignant disorders: the basis for novel immunotherapy protocols. Lancet Oncol 5 (2004) 47-55
14. Ruggeri L., Mancusi A., Burchielli E., Aversa F., Martelli M.F., and Velardi A. Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. Curr Opin Oncol 19 (2007) 142-147
15. Martin-Fontecha A., Thomsen L.L., Brett S., Gerard C., Lipp M., Lanzavecchia A., et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5 (2004) 1260-1265
16. Girart M.V., Fuertes M.B., Domaica C.I., Rossi L.E., and Zwirner N.W. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12. J Immunol 179 (2007) 3472-3479
17. Ikeda H., Old L.J., and Schreiber R.D. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 13 (2002) 95-109
18. Dunn G.P., Koebel C.M., and Schreiber R.D. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6 (2006) 836-848
19. Lauzon N.M., Mian F., MacKenzie R., and Ashkar A.A. The direct effects of Toll-like receptor ligands on human NK cell cytokine production and cytotoxicity. Cell Immunol 241 (2006) 102-112
20. Moretta L., Biassoni R., Bottino C., Cantoni C., Pende D., Mingari M.C., et al. Human NK cells and their receptors. Microbes Infect 4 (2002) 1539-1544
21. Ullrich E., Menard C., Flament C., Terme M., Mignot G., Bonmort M., et al. Dendritic cells and innate defense against tumor cells. Cytokine Growth Factor Rev (2007)
22. Vieira P.L., de Jong E.C., Wierenga E.A., Kapsenberg M.L., and Kalinski P. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J Immunol 164 (2000) 4507-4512
23. Zwirner N.W., Fuertes M.B., Girart M.V., Domaica C.I., and Rossi L.E. Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system. Cytokine Growth Factor Rev 18 (2007) 159-170
24. Karimi K., Boudreau J.E., Fraser K., Liu H., Delanghe J., Gauldie J., et al. Enhanced antitumor immunity elicited by dendritic cell vaccines is a result of their ability to engage both CTL and IFNgamma-producing NK cells. Mol Ther 16 (2008) 411-418
25. Fernandez N.C., Lozier A., Flament C., Ricciardi-Castagnoli P., Bellet D., Suter M., et al. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5 (1999) 405-411
26. Tosi D., Valenti R., Cova A., Sovena G., Huber V., Pilla L., et al. Role of cross-talk between IFN-alpha-induced monocyte-derived dendritic cells and NK cells in priming CD8+ T cell responses against human tumor antigens. J Immunol 172 (2004) 5363-5370
27. Cooper M.A., Fehniger T.A., Fuchs A., Colonna M., and Caligiuri M.A. NK cell and DC interactions. Trends Immunol 25 (2004) 47-52
28. Della C.M., Romagnani C., Thiel A., Moretta L., and Moretta A. Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses. Blood 108 (2006) 3851-3858
29. Ferlazzo G., and Munz C. NK cell compartments and their activation by dendritic cells. J Immunol 172 (2004) 1333-1339
30. Kalinski P., Giermasz A., Nakamura Y., Basse P., Storkus W.J., Kirkwood J.M., et al. Helper role of NK cells during the induction of anticancer responses by dendritic cells. Mol Immunol 42 (2005) 535-539
31. Moretta L., Ferlazzo G., Bottino C., Vitale M., Pende D., Mingari M.C., et al. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 214 (2006) 219-228
32. Cooper M.A., Fehniger T.A., and Caligiuri M.A. The biology of human natural killer-cell subsets. Trends Immunol 22 (2001) 633-640
33. Bryceson Y.T., March M.E., Ljunggren H.G., and Long E.O. Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107 (2006) 159-166
34. Mailliard R.B., Son Y.I., Redlinger R., Coates P.T., Giermasz A., Morel P.A., et al. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 171 (2003) 2366-2373
35. Le Bon A., and Tough D.F. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 14 (2002) 432-436
36. Ferrantini M., Capone I., and Belardelli F. Dendritic cells and cytokines in immune rejection of cancer. Cytokine Growth Factor Rev (2007)
37. Marcenaro E., Dondero A., and Moretta A. Multi-directional cross-regulation of NK cell function during innate immune responses. Transpl Immunol 17 (2006) 16-19
38. Swann J.B., Hayakawa Y., Zerafa N., Sheehan K.C., Scott B., Schreiber R.D., et al. Type I IFN contributes to NK cell homeostasis, activation, and antitumor function. J Immunol 178 (2007) 7540-7549
39. Smits E.L., Ponsaerts P., Van de Velde A.L., Van Driessche A., Cools N., Lenjou M., et al. Proinflammatory response of human leukemic cells to dsRNA transfection linked to activation of dendritic cells. Leukemia 21 (2007) 1691-1699
40. Van Tendeloo V.F., Ponsaerts P., Lardon F., Nijs G., Lenjou M., Van Broeckhoven C., et al. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98 (2001) 49-56
41. Fehniger T.A., Shah M.H., Turner M.J., VanDeusen J.B., Whitman S.P., Cooper M.A., et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J Immunol 162 (1999) 4511-4520
42. Matikainen S., Paananen A., Miettinen M., Kurimoto M., Timonen T., Julkunen I., et al. IFN-alpha and IL-18 synergistically enhance IFN-gamma production in human NK cells: differential regulation of Stat4 activation and IFN-gamma gene expression by IFN-alpha and IL-12. Eur J Immunol 31 (2001) 2236-2245
43. Mailliard R.B., Alber S.M., Shen H., Watkins S.C., Kirkwood J.M., Herberman R.B., et al. IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med 202 (2005) 941-953
44. Zitvogel L., Terme M., Borg C., and Trinchieri G. Dendritic cell-NK cell cross-talk: regulation and physiopathology. Curr Top Microbiol Immunol 298 (2006) 157-174
45. Degli-Esposti M.A., and Smyth M.J. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 5 (2005) 112-124
46. Sivori S., Falco M., Della C.M., Carlomagno S., Vitale M., Moretta L., et al. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 101 (2004) 10116-10121
47. Hart O.M., Athie-Morales V., O'Connor G.M., and Gardiner C.M. TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J Immunol 175 (2005) 1636-1642
48. Pisegna S., Pirozzi G., Piccoli M., Frati L., Santoni A., and Palmieri G. p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. Blood 104 (2004) 4157-4164
49. Schmidt K.N., Leung B., Kwong M., Zarember K.A., Satyal S., Navas T.A., et al. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol 172 (2004) 138-143
50. Strowig T., Brilot F., Arrey F., Bougras G., Thomas D., Muller W.A., et al. Tonsilar NK Cells Restrict B Cell Transformation by the Epstein-Barr Virus via IFN-gamma. PLoS Pathog 4 (2008) e27
51. Gerosa F., Gobbi A., Zorzi P., Burg S., Briere F., Carra G., et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 174 (2005) 727-734
52. Lowdell M.W., Craston R., and Prentice H.G. Generation of autologous immunity to acute myeloid leukaemia and maintenance of complete remission following interferon-alpha treatment. Cytokines Cell Mol Ther 5 (1999) 119-121
53. Cortes J.E., Kantarjian H.M., O'Brien S., Giles F., Keating M.J., Freireich E.J., et al. A pilot study of interleukin-2 for adult patients with acute myelogenous leukemia in first complete remission. Cancer 85 (1999) 1506-1513
54. Visani G., Martinelli G., Piccaluga P., Tosi P., Amabile M., Pastano R., et al. Alpha-interferon improves survival and remission duration in P-190BCR-ABL positive adult acute lymphoblastic leukemia. Leukemia 14 (2000) 22-27
55. Chan L., Hardwick N.R., Guinn B.A., Darling D., Gaken J., Galea-Lauri J., et al. An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia. Cancer Immunol Immunother 55 (2006) 1017-1024
56. Felger J.C., Alagbe O., Hu F., Mook D., Freeman A.A., Sanchez M.M., et al. Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression. Biol Psychiatry 62 (2007) 1324-1333
57. Verheyden S., and Demanet C. NK cell receptors and their ligands in leukemia. Leukemia 22 (2008) 249-257
58. Costello R.T., Fauriat C., Sivori S., Marcenaro E., and Olive D. NK cells: innate immunity against hematological malignancies?. Trends Immunol 25 (2004) 328-333
59. Ebata K., Shimizu Y., Nakayama Y., Minemura M., Murakami J., Kato T., et al. Immature NK cells suppress dendritic cell functions during the development of leukemia in a mouse model. J Immunol 176 (2006) 4113-4124
60. Fauriat C., Marcenaro E., Sivori S., Rey J., Gastaut J.A., Moretta A., et al. Natural killer cell-triggering receptors in patients with acute leukaemia. Leuk Lymphoma 44 (2003) 1683-1689